TWEAK/Fn14/UPR Signaling in Skeletal Muscle Wasting
骨骼肌萎缩中的 TWEAK/Fn14/UPR 信号转导
基本信息
- 批准号:10660397
- 负责人:
- 金额:$ 55.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:ATF6 geneAblationAccelerationAdultAdvanced Malignant NeoplasmAgingAntibodiesApcMin/+ miceApoptosis PromoterAtrophicAttenuatedBindingCachexiaCancer ModelCancer PatientCell Surface ReceptorsChronicChronic DiseaseComplicationDenervationDevelopmentDiseaseElderlyEndoplasmic ReticulumEukaryotic Initiation FactorsExerciseGene ExpressionGeneticHomeostasisIn VitroIndividualInduction of ApoptosisInflammationInflammatoryInositolKRASG12DKnockout MiceLinkMalignant NeoplasmsMediatingMediatorMembraneMetabolicMetabolic dysfunctionMitochondriaModelingMolecularMusMuscleMuscle FibersMuscle functionMuscular AtrophyNeuromuscular JunctionNutrientOrganellesOxidative StressPRKR genePathway interactionsPatientsPhosphotransferasesPopulationPreventionPrevention approachProkaryotic Initiation Factor-2Protein BiosynthesisProtein SecretionProteinsRNA SplicingRegulationReportingRepressionRoleSignal PathwaySignal TransductionSkeletal MuscleSkeletal Muscle NeoplasmStressSyndromeSystemTNF geneTherapeuticXBP1 geneactivating transcription factor 1agedarmcancer cachexiacell injurycytokineendoplasmic reticulum stressexperimental studyfrailtyimprovedin vivoknock-downmembermouse modelmuscle formnew therapeutic targetnovelnovel therapeutic interventionnovel therapeuticsoverexpressionpancreatic cancer modelpre-clinicalpreventprotein degradationprotein foldingreceptorresponsesarcopeniasensorskeletal muscle differentiationskeletal muscle growthskeletal muscle wastingtissue degenerationtumor
项目摘要
ABSTRACT
Skeletal muscle wasting/cachexia is a devastating complication of a number of chronic disease
states, such as cancer and in the elderly population. Muscle wasting involves an imbalance in
the rates of protein synthesis and degradation, functional denervation, metabolic abnormalities,
and loss of mitochondrial content and function. TWEAK is a proinflammatory cytokine that binds
to cell surface receptor Fn14 to activate multiple intracellular signaling pathways. We have
found that the expression of Fn14 is increased in skeletal muscle of mouse models of cancer
cachexia and in aged mice. Skeletal muscle-specific ablation of Fn14 inhibits muscle wasting in
a murine model of cancer cachexia. TWEAK represses the rate of protein synthesis in skeletal
muscle both in vivo and in vitro. Furthermore, the TWEAK-Fn14 system regulates ER stress-
induced unfolded protein response (UPR) in skeletal muscle of tumor-bearing mice. In addition,
our experiments demonstrate that targeted inhibition of the PERK and/or IRE1/XBP1 arms of
the UPR improves protein synthesis in skeletal muscle of mice. However, the role of the
TWEAK-Fn14 system and UPR pathways in the regulation of skeletal muscle mass and function
during cancer cachexia and aging remains completely unknown. In this project, we will
investigate the role of TWEAK/Fn14/UPR signaling axis in skeletal muscle atrophy and whether
targeted genetic ablation of Fn14 or components of the UPR attenuate muscle wasting in
preclinical mouse models of cancer cachexia and during aging. Based on our preliminary
results, we hypothesize that the TWEAK/Fn14 system causes skeletal muscle wasting through
the activation of the PERK and the IRE1α/XBP1 arms of the UPR during aging and cancer
cachexia. Our specific aims are to: (I) Investigate the role of the TWEAK/Fn14 system in
skeletal muscle wasting during aging and cancer cachexia, and (II) Investigate the mechanisms
by which TWEAK/Fn14-induced activation of the UPR pathways cause skeletal muscle wasting
during aging and cancer cachexia. Our proposed studies will identify key mechanisms
responsible for the loss of skeletal muscle mass. Successful completion of this project will
provide strong basis for the development of new therapies for sarcopenia and cancer cachexia.
摘要
骨骼肌萎缩/恶病质是许多慢性疾病的毁灭性并发症
如癌症和老年人。肌肉萎缩是指
蛋白质合成和降解的速率,功能性去神经支配,代谢异常,
以及线粒体内容和功能的丧失。TWEAK是一种促炎细胞因子,
细胞表面受体Fn 14激活多种细胞内信号通路。我们有
发现Fn 14的表达在癌症小鼠模型的骨骼肌中增加
恶病质和老年小鼠。骨骼肌特异性Fn 14消融抑制骨骼肌萎缩
癌症恶病质的小鼠模型。TWEAK抑制骨骼肌中蛋白质合成的速率
肌肉在体内和体外。此外,TWEAK-Fn 14系统调节ER应激-
在荷瘤小鼠的骨骼肌中诱导未折叠蛋白反应(UPR)。此外,本发明还提供了一种方法,
我们的实验表明,靶向抑制PERK和/或IRE 1/XBP 1臂,
UPR改善小鼠骨骼肌中的蛋白质合成。然而,
TWEAK-Fn 14系统和UPR通路在骨骼肌质量和功能调节中的作用
在癌症恶病质和衰老期间仍然完全未知。在这个项目中,我们将
研究TWEAK/Fn 14/UPR信号轴在骨骼肌萎缩中的作用,
Fn 14或UPR组分的靶向基因消融可减轻肌肉萎缩,
癌症恶病质和衰老过程中的临床前小鼠模型。根据我们初步的
结果,我们假设TWEAK/Fn 14系统通过以下途径引起骨骼肌萎缩:
在衰老和癌症期间UPR的PERK和IRE 1 α/XBP 1臂的激活
恶病质我们的具体目标是:(I)研究TWEAK/Fn 14系统在以下方面的作用:
衰老和癌症恶病质期间骨骼肌萎缩,以及(II)研究机制
通过TWEAK/Fn 14诱导的UPR通路激活导致骨骼肌萎缩
和癌症恶病质的影响。我们提议的研究将确定关键机制
导致骨骼肌质量下降。该项目的成功完成将
为开发肌少症和癌症恶病质的新疗法提供有力依据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ASHOK KUMAR其他文献
ASHOK KUMAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ASHOK KUMAR', 18)}}的其他基金
Non-Coding Variants of Angiotensinogen Gene and Hypertension
血管紧张素原基因的非编码变异与高血压
- 批准号:
9197334 - 财政年份:2016
- 资助金额:
$ 55.16万 - 项目类别:
Non-Coding Variants of Angiotensinogen Gene and Hypertension
血管紧张素原基因的非编码变异与高血压
- 批准号:
9325162 - 财政年份:2016
- 资助金额:
$ 55.16万 - 项目类别:
MYD88 Signaling in Mammalian Myoblast Fusion
哺乳动物成肌细胞融合中的 MYD88 信号转导
- 批准号:
9144184 - 财政年份:2015
- 资助金额:
$ 55.16万 - 项目类别:
MYD88 Signaling in Mammalian Myoblast Fusion
哺乳动物成肌细胞融合中的 MYD88 信号转导
- 批准号:
9336240 - 财政年份:2015
- 资助金额:
$ 55.16万 - 项目类别:
TAK1/TRAF6 Signaling in Skeletal Muscle
骨骼肌中的 TAK1/TRAF6 信号传导
- 批准号:
8502172 - 财政年份:2011
- 资助金额:
$ 55.16万 - 项目类别:
相似海外基金
心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
- 批准号:
24K11201 - 财政年份:2024
- 资助金额:
$ 55.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 55.16万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
- 批准号:
24K11281 - 财政年份:2024
- 资助金额:
$ 55.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
- 批准号:
EP/Z001145/1 - 财政年份:2024
- 资助金额:
$ 55.16万 - 项目类别:
Fellowship
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
职业:利用闭环装置控制热穿透深度和方向,实现精确烧蚀
- 批准号:
2338890 - 财政年份:2024
- 资助金额:
$ 55.16万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334777 - 财政年份:2024
- 资助金额:
$ 55.16万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334775 - 财政年份:2024
- 资助金额:
$ 55.16万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334776 - 财政年份:2024
- 资助金额:
$ 55.16万 - 项目类别:
Continuing Grant
MRI: Acquisition of a Laser Ablation - Inductively Coupled Plasma - Triple Quadrupole - Mass Spectrometer (LA-ICP-QQQ-MS) System For Research and Education
MRI:获取用于研究和教育的激光烧蚀 - 电感耦合等离子体 - 三重四极杆 - 质谱仪 (LA-ICP-MS/MS) 系统
- 批准号:
2320040 - 财政年份:2023
- 资助金额:
$ 55.16万 - 项目类别:
Standard Grant
Collaborative Research: CDS&E: An experimentally validated, interactive, data-enabled scientific computing platform for cardiac tissue ablation characterization and monitoring
合作研究:CDS
- 批准号:
2245152 - 财政年份:2023
- 资助金额:
$ 55.16万 - 项目类别:
Standard Grant